The global western blotting market is expected to reach US$1.4 billion by 2026 from US$1.0 billion in 2021, at a compound annual growth rate of 6.7%

during the forecast period. Technological developments, increasing government funding in biomedical research, growing demand for personalized medicine, and HIV prevalence are some of the major factors driving the growth of the market.

NEW YORK, NOV 25, 2021 (GLOBE NEWSWIRE) – announces release of “Western Blotting Market by Product,), Application, End User – Global Outlook to 2026 –

By instrument segment, the imaging equipment sub-segment is the fastest growing segment of the western blotting market
On the basis of instruments, the western blotting market is segmented into gel electrophoresis separators, blotting systems, and imaging devices. The growth in this product segment is mainly due to the automation of imaging devices, which simplifies the protein discovery process.

By end-user segment, the academic and research institutes segment captured the largest share of the western blotting market
Based on the end users, western blotting market is segmented into academic and research institutes, biopharma and biotechnology companies, hospitals, diagnostic laboratories and other end users in 2020, academic and research institutes captured the largest share of western blotting market. The large share of the end-user segment of academic and research institutes can be attributed to the increased government investment in research activities and the increase in research in the field of proteins.

Asia Pacific: The fastest growing region in the Western blotting market.
The Western blotting market in Asia Pacific is expected to register the highest growth during the forecast period. Key factors driving the growth of the Asia Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, presence of bioclusters in China and India, increased funding for life sciences research, and increased initiatives related to targeted disease diagnosis.

North America: the largest share of the western blotting market
In 2020, North America captured the largest share of western blotting market. Key factors driving the growth of this regional market include the presence of major Western blotting product manufacturers in this region, increased research funding, increased investments in protein research, and a growing focus on personalized medicine.

The details of the primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The primaries break up as follows:
• From the respondent side – supply side – 70%, demand side – 30%
• By appointment – executives and directors – 30%, executives – 25%, managers – 45%
• By region – North America – 40%, Europe – 25%, Asia Pacific – 20%, Latin America – 10%, Middle East and Africa – 5%

Notable companies in the western blotting market include Bio-Rad Laboratories, Inc. (US) and Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Bio-Techne Corporation (US), PerkinElmer, Inc. (US) and LI-COR, Inc. (US) and Advansta Inc. (US) and Cell Signaling Technology, Inc. (US) and F. Hoffmann-La Roche Ltd. (Switzerland) and Azure Biosystems, Inc. (US), Boster Biological Technology (US), Geno Technology Inc. (US), Rockland Immunochemicals, Inc. (US), Precision Biosystems (US), Cleaver Scientific Ltd. (UK), Abcam Plc (UK), The Proteintech Group (US) and Enzo Biochem, Inc. (US), Abnova Corporation (Taiwan), Sino Biological Inc (China), StressMarq Biosciences Inc. (Canada) and Abbexa Ltd. (UK), Covalab SAS (France), and Biorbyt Ltd (UK).

Research coverage:
The report segments the Western Blotting Market based on region (Asia Pacific, Europe, North America, Latin America, Middle East & Africa) and product (Consumables) [Reagents & Buffers, Antibodies & Conjugates {Primary Antibodies, Secondary Antibodies, Other Antibodies & Conjugates}, Kits
Membranes & Filter Papers Other Consumables], Tools [Electrophoresis, Blotting Systems {Semi-dry Blotting Systems, Wet Blotting Systems}, Imagers {Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers}]), Application (Biomedical Research, Clinical Diagnostics [HIV, Lyme Disease, Hepatitis, Other Diseases], agricultural, and other applications), and end user (academic and research institutes, biopharma and biotechnology companies, hospitals and diagnostic laboratories, and other users). The report also provides a comprehensive review of market drivers, opportunity restraints, challenges and trends in the Western Blotting market.

The main benefits of purchasing the report:
The report will help the new leaders / entrants in this market with information on the closest approximations of revenue figures for the total market and sub-segments, this report will help the stakeholders to understand the competitive landscape and gain more ideas to improve their business position. and planning appropriate market entry strategies.

The report also helps stakeholders to understand the pulse of the Western Beverage market and provides them with information on major market drivers, restraints, challenges, and opportunities.
Read the full report:

About Reportlinker
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you have all the market research you need – instantly, in one place.


CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

Write a Comment

Your email address will not be published. Required fields are marked *